Intra Cellular Therapies reported $601.3M in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 645.73M 28.25M
Adamas Pharmaceuticals ADMS:US 115.66M 42.45M
Aptinyx Inc APTX:US $ 133.78M 18.63M
Arena Pharmaceuticals ARNA:US $ 990.44M 131.17M
Biogen BIIB:US $ 7183.7M 464.2M
Bristol Myers Squibb BMY:US $ 29161M 2050M
Cytokinetics CYTK:US $ 364.23M 68.89M
Esperion Therapeutics ESPR:US $ 275.17M 2.6M
Gilead Sciences GILD:US $ 14498M 1220M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Halozyme Therapeutics HALO:US $ 999.75M 58.03M
Intra Cellular Therapies ITCI:US $ 601.3M 47.8M
JAZZ PHA JAZZ:US $ 2953.96M 212.93M
Marinus Pharmaceuticals MRNS:US $ 120.92M 8.87M
Minerva Neurosciences NERV:US $ 75.22M 6.46M
Nektar Therapeutics NKTR:US $ 1056.15M 42.9M
Neurocrine Biosciences NBIX:US $ 1110.1M 24.7M
Novartis NVS:US $ 23808M 1610M
Prothena PRTA:US 409.47M 57.17M
Redhill Biopharma RDHL:US $ 98.49M 14.17M
Supernus Pharmaceuticals SUPN:US $ 639.24M 53.22M
United Therapeutics UTHR:US $ 2317.9M 303.6M
Vanda Pharmaceuticals VNDA:US $ 446.65M 25.43M
Zogenix ZGNX:US $ 416.39M 38.34M